Information  X 
Enter a valid email address

AstraZeneca PLC (AZN)

  Print      Mail a friend       Annual reports

Monday 27 February, 2012

AstraZeneca PLC

Director/PDMR Shareholding

RNS Number : 2082Y
AstraZeneca PLC
27 February 2012
 



Transaction by Persons Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

 

The interest of David Brennan, a Director of the Company, in AstraZeneca PLC Ordinary Shares of $0.25 each, has changed as detailed below. 

 

On 24 February 2012, Mr Brennan was allocated 15,498 shares under the previously disclosed arrangements relating to the payment of annual bonuses whereby he is required to defer a portion of the bonus earned into shares for a period of three years.  The shares were allocated at a price of 2851 pence per share.  Mr Brennan will become beneficially entitled to these shares on 24 February 2015.

 

Mr Brennan has interests in both the Ordinary Shares and the American Depositary Shares (ADSs) of AstraZeneca PLC.  One ADS equals one Ordinary Share.

 

As a result of this transaction, Mr Brennan has an interest in 671,918 Ordinary Shares and 81,229 AstraZeneca ADSs, which together represent approximately 0.06% of the Company's issued ordinary capital.

 

A C N Kemp

Company Secretary

27 February 2012


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUBOVRUSAUUAR

a d v e r t i s e m e n t